Discrimination between dementia with Lewy bodies and Alzheimer's disease based on biofluid monoamines, biomarker values and cognitive parameters

A Heylen, Y Vermeiren, D Van Dam, PP De Deyn - Alzheimer's & Dementia - library.wur.nl
Background Despite disease-specific symptoms, differentiation between Alzheimer's
disease (AD) and dementia with Lewy bodies (DLB) remains challenging, especially in …
相关文章

Discrimination between dementia with Lewy bodies and Alzheimer's disease based on biofluid monoamines, biomarker values and cognitive parameters

A Heylen - edepot.wur.nl
Background: Despite disease-specific symptoms, differentiation between Alzheimer's
disease (AD) and dementia with Lewy bodies (DLB) remains challenging, especially in …

[引用][C] Discrimination between dementia with Lewy bodies and Alzheimer's disease based on biofluid monoamines, biomarker values and cognitive parameters

A Heylen, Y Vermeiren - Alzheimer's & Dementia, 2023 - research.wur.nl
Discrimination between dementia with Lewy bodies and Alzheimer’s disease based on biofluid
monoamines, biomarker values and cognitive parameters — Research@WUR Skip to main …

[引用][C] Discrimination between dementia with Lewy bodies and Alzheimer's disease based on biofluid monoamines, biomarker values and cognitive parameters

A Heylen, Y Vermeiren, D Van Dam… - Alzheimer's Association …, 2023 - alz.confex.com

Discrimination between dementia with Lewy bodies and Alzheimer's disease based on biofluid monoamines, biomarker values and cognitive parameters

A Heylen, Y Vermeiren, D Van Dam… - Alzheimer's & …, 2023 - Wiley Online Library
Background Despite disease‐specific symptoms, differentiation between Alzheimer's
disease (AD) and dementia with Lewy bodies (DLB) remains challenging, especially in …